FindTrial
Sign In

Commonness of Ringworm infection and effectiveness of antifungal medicines.

Prevalence of Dermatophytosis and their antifungal susceptibility pattern - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100893
Enrollment
90
Registered
2026-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B358- Other dermatophytoses

Interventions

Intervention1: Antifungal susceptibility pattern for Dermatophytosis case: Antifungal susceptibility for drugs Itraconazole,Terbinafine, Griseofulvin, Fluconazole. Total duration- 2 years Intervention

Sponsors

Dr Sarath Chandar C
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically suspected cases of dermatophytosis of all age groups attending Dermatology OPD

Exclusion criteria

Exclusion criteria: Patients with non dermatyophytic fungal infections

Design outcomes

Primary

MeasureTime frame
To determine the most prevalent dermatophyte species isolated from patients attending the hospitalTimepoint: 2 years—

Secondary

MeasureTime frame
To assess the antifungal susceptibility pattern of dermatophyte isolates to commonly used anttifungal agentsTimepoint: 2 years—

Countries

India

Contacts

Public ContactDrAVRaghavendra rao

Vinayaka Missions Kirupananda Variyar Medical College and Hospitals, Salem

dravrrao@gmail.com8428395339

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026